Business Relations Table - o4.fyi ()

Anmelden Gast|Guest

Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

s

p

o

BR-Editor

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol für reply

Bliss Symbol

Bliss Symbol für reply

Domain-Statistiken für "cantex.com"

13

Business Relations

14

Eindeutige Domains

13

Gefundene Einträge

BR-Relations: 13

From Domain	Role	To Domain	Path	Aktionen
cantex.com	>>isreferencefrom.png CID: 0	multiplesclerosisnewstoday.com	/news-posts/2026/05/15/partners-use-ai-fast-track-azeliragon-ms-depression-fatigue/
cantex.com	>>isreferencefrom.png CID: 0	bostonmatrix.org	/
cantex.com	>>isreferencefrom.png CID: 0	pullanconsulting.com	/clients
cantex.com	>>isreferencefrom.png CID: 0	wyss.harvard.edu	/news/cantex-licenses-intellectual-property-from-harvard-university-to-develop-repurposed-drug-identified-by-wyss-institute-to-treat-inflammatory-lung-diseases-including-covid-19/
cantex.com	>>isreferencefrom.png CID: 0	distrilist.eu	/most-innovative-pharmaceutical-companies-in-usa-691-listed/
cantex.com	>>isreferencefrom.png CID: 0	technewslit.com	/
cantex.com	>>isreferencefrom.png CID: 0	globalhealthnewswire.com	/technology/2022/02/24/cantex-licenses-intellectual-property-from-harvard-university-to-develop-repurposed-drug-identified-by-wyss-institute-to-treat-inflammatory-lung-diseases-including-covid-19
cantex.com	>>isreferencefrom.png CID: 0	pharmashots.com	/17500/new-drug-designations-may-2024/
cantex.com	>>isreferencefrom.png CID: 0	pharmajournalist.com	/cantex-pharmaceuticals-cx-01-product-severe-myeloid-leukemia-studies-reveal-immense-respite-rates/
cantex.com	>>isreferencefrom.png CID: 0	whatnext.com	/azeliragon-orphan-drug-designation-pancreatic-cancer/
cantex.com	>>isreferencefrom.png CID: 0	sciwri.club	/archives/5987
cantex.com	>>isreferencefrom.png CID: 0	drugdiscoverynews.com	/taking-aim-at-aml-13631
cantex.com	>>isreferencefrom.png CID: 0	biospace.com	/business/5-biotechs-taking-the-pipeline-in-a-product-approach-to-drug-development